AlphAIalphai — Financial news for AI agents
rttnews.comAUG 172 min read$CRGO

Freightos Q2 Loss Narrows, Announces Q3, FY26 Outlook; Stock Up In Pre-Market

Freightos Limited (CRGO) reported Q2 2026 loss of $1.6M, narrower than $4.2M a year earlier, helped by a $1.8M fair-value gain on warrants. Non-IFRS loss was $1.9M ($0.04/share). Revenue rose to $7.7M from $7.4M. Q3 revenue guidance is $7.7M-$7.8M and FY26 $30.4M-$31.0M. Shares were up 12.61% pre-market at $1.52.

Original reporting
rttnews.com
Published Aug 17, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 12:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Freightos Q2 Loss Narrows, Announces Q3, FY26 Outlook; Stock Up In Pre-Market — source image
Source · rttnews.com
Decision brief

The 30-second read

$CRGOBullishMed
01

Why it matters

The key tradable inputs are the Q3 and FY26 revenue ranges and the composition of the loss narrowing (including warrant fair-value gains).

02

Market read

A microcap earnings-and-guidance update with a same-day pre-market reaction, offering a concrete near-term catalyst for positioning.

03

What to watch

SaaS revenue performance was lower than expected, so the market may re-rate the quality of growth even with higher-than-expected customs and WebCargo revenue.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Freightos Limited (CRGO) released Q2 2026 financial results and provided forward revenue guidance for Q3 and FY26.

Company-level read

Ticker impact

$CRGOBullishMedium confidence
Context

Freightos reported Q2 2026 results with a narrower loss and guided Q3 and FY26 revenue ranges, driving a pre-market stock jump.

Expected impact

Bullish bias for the next session, with volatility risk if investors focus on non-IFRS adjustments and SaaS underperformance.

Evidence & confidence

The article provides fresh Q3 and FY26 revenue ranges plus a same-day pre-market move, but it also attributes improvement partly to a $1.8M fair-value warrant gain rather than core operating strength.

Market effects

Sector

Signals continued demand for digital freight and customs-related transaction revenue, while SaaS performance remains a watch item.

Regional

No specific regional impact described beyond Nasdaq trading.

Global

No explicit global macro or cross-border regulatory impacts mentioned.

Counterpoint

What could challenge this read

Investors may discount the earnings improvement because it is partly driven by a fair-value warrant gain rather than recurring operations.

Key entities

  • company
    Freightos Limited

    Reported Q2 2026 loss narrowing, provided Q3 and FY26 revenue guidance, and is trading higher pre-market.

Read at source← All news

Related articles

MAY 26
$CRGOHighAI 9/10

Freightos Q1 Earnings Call Highlights

Freightos reported Q1 revenue of $7.2 million, up 3% year over year, with non-IFRS gross margin of 73.5% and adjusted EBITDA loss of $2.8 million, management said was in line with expectations. Cash was $23.5 million. The company began a cost optimization plan in late March targeting ~$4.5 million annualized savings from Q4 2026 and adjusted EBITDA breakeven by end-2026, and updated its outlook for softer transaction growth.

finance.yahoo.com6 min
AUG 17
$LONAMed

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances

LeonaBio (NASDAQ:LONA) reported a Q2 loss of $0.80 per share, smaller than analysts’ $1.12 forecast. Net loss rose to $19.0 million from $7.0 million a year earlier. Phase 3 ELAINE-3 enrollment nears 600 target, with 495 patients enrolled and topline results expected in H2 2027. Cash fell to $51.1 million from $88.3 million.

yahoo.com4 min
AUG 17
$JSPRMed

Jasper Therapeutics beats Q2 expectations but shares fall after results

Jasper Therapeutics (NASDAQ:JSPR) reported Q2 2026 adjusted loss of $0.10 per share, better than the $0.28 consensus, and a net loss of $2.8 million. Shares fell 4.24% pre-market. In July, Jasper completed an all-stock acquisition of Kira Pharmaceuticals and a $132 million private placement, extending its funding runway into 2H 2028. Pipeline updates include KP-104 Phase 2 interim data in Q4 2026 and briquilimab and KP-701 milestones in early 2027.

yahoo.com4 min
AUG 17
$PPSIMed

PIONEER POWER SOLUTIONS, INC. (PPSI): Results of Operations and Financial Condition

PIONEER POWER SOLUTIONS, INC. (PPSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Pioneer Power Announces Financial Results for Second Quarter 2026 and Provides a Business Update ● Backlog Grew 32% Sequentially to $18.4 Million ● Projecting Revenue of Approximately $15 Million in Second Half of 2026, Representing More

SEC EDGAR 8-K6 min
AUG 17
$BDCOMed

BLUE DOLPHIN ENERGY CO (BDCO): Results of Operations and Financial Condition

BLUE DOLPHIN ENERGY CO (BDCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_967513.htm EXHIBIT 99.1 BDCO EARNINGS RLS DATED AUGUST 17, 2026 ex_967513.htm Exhibit 99.1 PRESS RELEASE FOR IMMEDIATE RELEASE BLUE DOLPHIN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ● Total gross profit of $25.1 million and $45.7 million for the three and six mon

SEC EDGAR 8-K4 min